ID24332A - Komposisi yang mengandung partikel budesonida berbentuk kristal yang halus - Google Patents

Komposisi yang mengandung partikel budesonida berbentuk kristal yang halus

Info

Publication number
ID24332A
ID24332A IDW991396A ID991396A ID24332A ID 24332 A ID24332 A ID 24332A ID W991396 A IDW991396 A ID W991396A ID 991396 A ID991396 A ID 991396A ID 24332 A ID24332 A ID 24332A
Authority
ID
Indonesia
Prior art keywords
composition
fine crystal
contains budesonide
budesonide particle
particle
Prior art date
Application number
IDW991396A
Other languages
English (en)
Indonesian (id)
Inventor
Mikael Bisrat
Saeed Moshashaee
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of ID24332A publication Critical patent/ID24332A/id

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IDW991396A 1997-05-23 1998-05-15 Komposisi yang mengandung partikel budesonida berbentuk kristal yang halus ID24332A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9701956A SE9701956D0 (sv) 1997-05-23 1997-05-23 New composition of matter

Publications (1)

Publication Number Publication Date
ID24332A true ID24332A (id) 2000-07-13

Family

ID=20407079

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW991396A ID24332A (id) 1997-05-23 1998-05-15 Komposisi yang mengandung partikel budesonida berbentuk kristal yang halus

Country Status (28)

Country Link
US (2) US6346523B1 (da)
EP (1) EP1005328B1 (da)
JP (1) JP2001525850A (da)
KR (1) KR100514971B1 (da)
CN (1) CN1146406C (da)
AR (1) AR015820A1 (da)
AT (1) ATE246492T1 (da)
AU (1) AU734763B2 (da)
BR (1) BR9808812A (da)
CA (1) CA2290538C (da)
DE (1) DE69816997T2 (da)
DK (1) DK1005328T3 (da)
EE (1) EE03850B1 (da)
ES (1) ES2205496T3 (da)
HU (1) HUP0002212A3 (da)
ID (1) ID24332A (da)
IL (1) IL133098A (da)
IS (1) IS5254A (da)
NO (1) NO995540D0 (da)
NZ (1) NZ500852A (da)
PL (1) PL336902A1 (da)
PT (1) PT1005328E (da)
SE (1) SE9701956D0 (da)
SK (1) SK158799A3 (da)
TR (1) TR199902880T2 (da)
TW (1) TW518236B (da)
WO (1) WO1998052544A1 (da)
ZA (1) ZA984127B (da)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69633222T2 (de) * 1995-02-24 2005-09-08 Elan Pharma International Ltd. Nanopartikel-dispersionen enthaltende aerosole
EP1263516A1 (en) * 2000-03-03 2002-12-11 Boehringer Ingelheim Pharmaceuticals Inc. Material processing by repeated solvent expansion-contraction
WO2002051381A1 (fr) * 2000-12-26 2002-07-04 Takeda Chemical Industries, Ltd. Substance poreuse et son procede de fabrication
GB0106403D0 (en) * 2001-03-15 2001-05-02 Pharmaceutical Profiles Labelling of dry powder formulations for inhalation
GB0208742D0 (en) 2002-04-17 2002-05-29 Bradford Particle Design Ltd Particulate materials
EP1423175B1 (en) 2001-08-08 2013-10-02 Brown University Research Foundation Methods for micronization of hydrophobic drugs
DE60211004T2 (de) 2001-10-10 2006-08-31 Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield Pulververarbeitung mit unter druck stehenden gasförmigen fluids
US20030129242A1 (en) * 2002-01-04 2003-07-10 Bosch H. William Sterile filtered nanoparticulate formulations of budesonide and beclomethasone having tyloxapol as a surface stabilizer
GB0216562D0 (en) * 2002-04-25 2002-08-28 Bradford Particle Design Ltd Particulate materials
US9339459B2 (en) 2003-04-24 2016-05-17 Nektar Therapeutics Particulate materials
JP2007501683A (ja) 2003-05-22 2007-02-01 エラン ファーマ インターナショナル リミテッド γ線照射によるナノ粒子活性物質分散体の滅菌法
TWI359675B (en) 2003-07-10 2012-03-11 Dey L P Bronchodilating β-agonist compositions
US20070020299A1 (en) * 2003-12-31 2007-01-25 Pipkin James D Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid
US20070020196A1 (en) * 2003-12-31 2007-01-25 Pipkin James D Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid prepared from a unit dose suspension
US20070020298A1 (en) * 2003-12-31 2007-01-25 Pipkin James D Inhalant formulation containing sulfoalkyl ether gamma-cyclodextrin and corticosteroid
WO2005088655A1 (en) * 2004-03-12 2005-09-22 The Provost Fellows And Scholars Of The College Of The Holy And Undivided Trinity Of Queen Elizabeth Near Dublin A magnetoresistive medium
WO2006096906A1 (en) * 2005-03-18 2006-09-21 Nanomaterials Technology Pte Ltd Inhalable drug
US8475845B2 (en) 2005-07-15 2013-07-02 Map Pharmaceuticals, Inc. Method of particle formation
EP1782839A1 (en) 2005-11-03 2007-05-09 Genetic S.p.A. Sterilization process of Glucocorticosteroid by supercritical CO2
US20070160542A1 (en) * 2005-12-20 2007-07-12 Verus Pharmaceuticals, Inc. Methods and systems for the delivery of corticosteroids having an enhanced pharmacokinetic profile
US20070197486A1 (en) * 2005-12-20 2007-08-23 Verus Pharmaceuticals, Inc. Methods and systems for the delivery of corticosteroids
US20070185066A1 (en) * 2005-12-20 2007-08-09 Verus Pharmaceuticals, Inc. Systems and methods for the delivery of corticosteroids
US20070249572A1 (en) * 2005-12-20 2007-10-25 Verus Pharmaceuticals, Inc. Systems and methods for the delivery of corticosteroids
US20070178049A1 (en) * 2005-12-20 2007-08-02 Verus Pharmaceuticals, Inc. Systems and methods for the delivery of corticosteroids having an enhanced pharmacokinetic profile
US20070178051A1 (en) * 2006-01-27 2007-08-02 Elan Pharma International, Ltd. Sterilized nanoparticulate glucocorticosteroid formulations
CA2642579A1 (en) * 2006-02-15 2007-08-23 Tika Lakemedel Ab Sterilization of corticosteroids with reduced mass loss
KR20150041804A (ko) 2007-02-11 2015-04-17 맵 파마슈티컬스, 인코포레이티드 부작용 프로파일을 최소화하면서 편두통의 빠른 완화를 가능하게 하는 ｄｈｅ의 치료적 투여 방법
US20100294986A1 (en) * 2009-05-19 2010-11-25 Massachusetts Institute Of Technology Supercritical fluid facilitated particle formation in microfluidic systems
US20100298602A1 (en) * 2009-05-19 2010-11-25 Massachusetts Institute Of Technology Systems and methods for microfluidic crystallization
US8574630B2 (en) * 2010-09-22 2013-11-05 Map Pharmaceuticals, Inc. Corticosteroid particles and method of production
CN102975731B (zh) * 2012-04-24 2015-08-12 南车南京浦镇车辆有限公司 轨道车辆司机室骨架与车体的安装结构
WO2021219230A1 (en) 2020-04-30 2021-11-04 Paolo Fiorina Antiviral treatment
KR102567655B1 (ko) 2020-11-13 2023-08-17 주식회사 비츠로이엠 진공커패시터 및 진공커패시터 제조 방법
KR20230072023A (ko) 2021-11-17 2023-05-24 주식회사 비츠로이엠 가변형 진공 커패시터의 나선형 전극 위치 결정구조
KR20230072022A (ko) 2021-11-17 2023-05-24 주식회사 비츠로이엠 가변형 진공 커패시터

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1282405C (en) 1984-05-21 1991-04-02 Michael R. Violante Method for making uniformly sized particles from water-insoluble organic compounds
JP2843857B2 (ja) 1988-10-05 1999-01-06 ファルマシア・アンド・アップジョン・カンパニー 反溶剤への沈澱を介する微細分化固体結晶性粉末
GB9001635D0 (en) 1990-01-24 1990-03-21 Ganderton David Aerosol carriers
ES2078447T3 (es) 1990-06-15 1995-12-16 Merck & Co Inc Un procedimiento de cristalizacion para mejorar la estructura y el tamaño de los cristales.
SE9302777D0 (sv) 1993-08-27 1993-08-27 Astra Ab Process for conditioning substances
US5874063A (en) * 1991-04-11 1999-02-23 Astra Aktiebolag Pharmaceutical formulation
HU0004452D0 (da) * 1991-12-18 2001-01-29 Astra Ab
GB9313642D0 (en) * 1993-07-01 1993-08-18 Glaxo Group Ltd Method and apparatus for the formation of particles
SE9501384D0 (sv) 1995-04-13 1995-04-13 Astra Ab Process for the preparation of respirable particles

Also Published As

Publication number Publication date
PT1005328E (pt) 2003-11-28
SE9701956D0 (sv) 1997-05-23
PL336902A1 (en) 2000-07-17
ES2205496T3 (es) 2004-05-01
EE03850B1 (et) 2002-10-15
CA2290538A1 (en) 1998-11-26
ZA984127B (en) 1998-11-23
IS5254A (is) 1999-11-18
KR20010012821A (ko) 2001-02-26
EP1005328B1 (en) 2003-08-06
CN1146406C (zh) 2004-04-21
ATE246492T1 (de) 2003-08-15
EE9900533A (et) 2000-06-15
US20020037257A1 (en) 2002-03-28
KR100514971B1 (ko) 2005-09-15
TR199902880T2 (xx) 2000-02-21
IL133098A (en) 2005-03-20
DE69816997T2 (de) 2004-07-22
WO1998052544A1 (en) 1998-11-26
NO995540L (no) 1999-11-12
AU734763B2 (en) 2001-06-21
NO995540D0 (no) 1999-11-12
HUP0002212A3 (en) 2001-04-28
NZ500852A (en) 2001-07-27
JP2001525850A (ja) 2001-12-11
US6346523B1 (en) 2002-02-12
DE69816997D1 (de) 2003-09-11
HUP0002212A2 (hu) 2000-12-28
BR9808812A (pt) 2000-07-18
CN1257424A (zh) 2000-06-21
AU7680098A (en) 1998-12-11
CA2290538C (en) 2007-01-02
EP1005328A1 (en) 2000-06-07
SK158799A3 (en) 2000-05-16
IL133098A0 (en) 2001-03-19
TW518236B (en) 2003-01-21
AR015820A1 (es) 2001-05-30
US6468994B2 (en) 2002-10-22
DK1005328T3 (da) 2003-11-17

Similar Documents

Publication Publication Date Title
ID24332A (id) Komposisi yang mengandung partikel budesonida berbentuk kristal yang halus
ID16493A (id) Perlakuan bahan yang mengandung padatan yang diambil dari efluen
DE69932552D1 (de) Pulver-Zusammensetzung und kosmetische Zusammensetzung enthaltend dieselbe
GB2334718B (en) Phenylacetylene compound and liquid crystal composition comprising the same
ID21236A (id) Penggunaan komposisi bioaktif yang dikapsulkan
HK1068328A1 (en) Naphthalene derivative and liquid crystal composition comprising the same
ID27798A (id) Pengeras suara-pengeras suara yang terdiri dari anggota berbentuk panel yang bergema
ID20627A (id) Komposisi bahan pengikat tekstil mengandung serbuk yang dapat berikatan silang
ZA985274B (en) Improvements in or relating to the cleansing of surfaces
FI956324A (fi) Organofunktionaalisten polysiloksaanien käyttö hienojakoisten hiukkasten pintojen modifioimiseksi
ZA985206B (en) Binder compositions use thereof and a process for the manufacture of particle board
ID28382A (id) Bahan anti keringat dan komposisi-komposisi yang mengandung bahan anti keringat
GB9509882D0 (en) CRT adhesive composition and CRT obtained by the use thereof
GB2340936B (en) Improvements relating to the measurement of particle size distribution
AU4057197A (en) Composition to aid in the forming of metal
DE69413610D1 (de) Teilchen Zementzusammensetzungen
HUP0001858A3 (en) Bi-aromatic compounds and pharmaceutical and cosmetic compositions containing same and the use of the compounds
GB9811168D0 (en) Direct hair-colouring compositions and the use thereof
GB0115657D0 (en) High quality surface engineering of domain structures in congruent lithium niobate single crystals
SG70106A1 (en) Ceramic flash evaporation boats for use in the manufacture of televisions
ID29101A (id) Komposisi yang mengandung bitumen dalam bentuk butiran
FI952953A (fi) Aineita metabolisten luustosairauksien hoitamiseen
GB2286286B (en) Improvements in or relating to the fabrication of semiconductor devices
HUP0100733A3 (en) Amidino compounds for use in the treatment of chronic obstructive pulmonary
GB2340937B (en) Improvements relating to the measurement of particle size distribution